Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Ricart

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
Gastroenterologia Y Hepatologia|April 13, 2010
[Rationale for cell therapy in the treatment of inflammatory bowel disease]Ingrid Ordás, Azucena Salas, Daniel Benítez, et al.
Abdominal Imaging|November 11, 2011
Imaging indexes of activity and severity for Crohn's disease: current status and future trendsJordi Rimola, Ingrid Ordás, Sonia Rodríguez, et al.
Plos One|January 10, 2013
Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cellsRaquel Cabezón, Elena Ricart, Carolina España, et al.
Current Drug Targets|June 6, 2012
Imaging of the colon in inflammatory bowel disease: ready for prime time?Ingrid Ordas, Jordi Rimola, Sonia Rodriguez, et al.
World Journal of Gastroenterology|February 27, 2023
Medical consultation in ulcerative colitis: Key elements for improvementYago González-Lama, Elena Ricart, Ana Cábez, et al.
Current Drug Targets|October 29, 2013
Cell therapies for IBD: what works?Elena Ricart, Aranzazu Jauregui-Amezaga, Ingrid Ordás, et al.
Dermatology Reports|November 12, 2014
Neutrophilic dermatoses in a patient with collagenous colitisDidac Barco, Maria A Barnadas, Esther Roé, et al.
European Journal of Gastroenterology & Hepatology|May 1, 2009
Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease versionMercedes Vergara, Antònia Montserrat, Francesc Casellas, et al.
Journal of Crohn'S & Colitis|June 9, 2012
Risk of developing tuberculosis under anti-TNF treatment despite latent infection screeningAranzazu Jauregui-Amezaga, Fanny Turon, Ingrid Ordás, et al.
Inflammatory Bowel Diseases|February 25, 2009
Risk factors and characteristics of extent progression in ulcerative colitisMaría Josefina Etchevers, Montserrat Aceituno, Orlando García-Bosch, et al.
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Gastroenterologia Y Hepatologia|April 13, 2010
[Rationale for cell therapy in the treatment of inflammatory bowel disease]Ingrid Ordás, Azucena Salas, Daniel Benítez, et al.
Abdominal Imaging|November 11, 2011
Imaging indexes of activity and severity for Crohn's disease: current status and future trendsJordi Rimola, Ingrid Ordás, Sonia Rodríguez, et al.
Plos One|January 10, 2013
Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cellsRaquel Cabezón, Elena Ricart, Carolina España, et al.
Current Drug Targets|June 6, 2012
Imaging of the colon in inflammatory bowel disease: ready for prime time?Ingrid Ordas, Jordi Rimola, Sonia Rodriguez, et al.
World Journal of Gastroenterology|February 27, 2023
Medical consultation in ulcerative colitis: Key elements for improvementYago González-Lama, Elena Ricart, Ana Cábez, et al.
Current Drug Targets|October 29, 2013
Cell therapies for IBD: what works?Elena Ricart, Aranzazu Jauregui-Amezaga, Ingrid Ordás, et al.
Dermatology Reports|November 12, 2014
Neutrophilic dermatoses in a patient with collagenous colitisDidac Barco, Maria A Barnadas, Esther Roé, et al.
European Journal of Gastroenterology & Hepatology|May 1, 2009
Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease versionMercedes Vergara, Antònia Montserrat, Francesc Casellas, et al.
Journal of Crohn'S & Colitis|June 9, 2012
Risk of developing tuberculosis under anti-TNF treatment despite latent infection screeningAranzazu Jauregui-Amezaga, Fanny Turon, Ingrid Ordás, et al.
Inflammatory Bowel Diseases|February 25, 2009
Risk factors and characteristics of extent progression in ulcerative colitisMaría Josefina Etchevers, Montserrat Aceituno, Orlando García-Bosch, et al.
Pageof 14